Related Experiment Video
Updated: Jul 17, 2026
05:10
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
Linking laboratory and medication data: new opportunities for pharmacoepidemiological research
Maarten J ten Berg1, Albert Huisman, Patricia M L A van den Bemt
1Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences, Utrecht, The Netherlands.
Clinical Chemistry and Laboratory Medicine
|January 25, 2007
Summary
The Utrecht Patient Oriented Database (UPOD) links clinical laboratory data with other patient information. This enables cost-effective clinical epidemiological research and improves patient care.
Area of Science:
- Clinical Epidemiology
- Health Informatics
Background:
- Automated laboratory data integration into databases facilitates clinical epidemiological research.
- Linking laboratory data with administrative and clinical data offers cost-effective disease and therapeutic investigations.
Purpose of the Study:
- To establish the Utrecht Patient Oriented Database (UPOD) for comprehensive clinical research.
- To leverage UPOD for innovative research, particularly linking laboratory and medication data.
Main Methods:
- Established UPOD, a relational database infrastructure at University Medical Centre Utrecht since 2004.
- Integrated patient characteristics, laboratory results, medication orders, diagnoses, and procedures.
- Focused research on linking laboratory and medication data.
Main Results:
- UPOD enables investigation of pharmacotherapy quality and drug-test interactions.
- Facilitates research on adverse drug reaction risks and diagnostic/prognostic markers.
- Broadens opportunities for clinical pharmacoepidemiological research.
Conclusions:
- UPOD enhances clinical pharmacoepidemiological research capabilities.
- The database infrastructure contributes to improved patient care from a laboratory perspective.
Related Concept Videos
01:19Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:20Measurement of Bioavailability: Pharmacodynamic Methods
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
01:12Analysis of Population Pharmacokinetic Data
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
01:26Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...